Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Malignant Lymphoma

  Free Subscription


Articles published in Radiother Oncol

Retrieve available abstracts of 15 articles:
HTML format



Single Articles


    October 2020
  1. SERTORIO M, Nowrouzi A, Akbarpour M, Chetal K, et al
    Differential transcriptome response to proton versus X-ray radiation reveals novel candidate targets for combinatorial PT therapy in lymphoma.
    Radiother Oncol. 2020 Oct 20. pii: S0167-8140(20)30860.
    PubMed     Abstract available


    July 2020
  2. NIELSEN K, Vestmoe Maraldo M, Kiil Berthelsen A, Loft A, et al
    Involved node radiation therapy in the combined modality treatment for early-stage Hodgkin lymphoma: Analysis of relapse location and long-term outcome.
    Radiother Oncol. 2020 Jul 2. pii: S0167-8140(20)30382.
    PubMed     Abstract available


    June 2020
  3. ZHU LL, Martin RM, Gunther JR, Wong PF, et al
    Daily computed tomography image guidance: dosimetric advantages outweigh low-dose radiation exposure for treatment of mediastinal lymphoma.
    Radiother Oncol. 2020 Jun 25. pii: S0167-8140(20)30353.
    PubMed     Abstract available


    May 2020
  4. DURHAM AD, Lovis A, Simons J, Long O, et al
    Percussion assisted radiation therapy in Hodgkin lymphoma allows a marked reduction in heart dose.
    Radiother Oncol. 2020 May 21. pii: S0167-8140(19)33475.
    PubMed     Abstract available


    May 2019
  5. LEVIS M, Filippi AR, Fiandra C, De Luca V, et al
    Inclusion of heart substructures in the optimization process of volumetric modulated arc therapy techniques may reduce the risk of heart disease in Hodgkin's lymphoma patients.
    Radiother Oncol. 2019;138:52-58.
    PubMed     Abstract available


  6. TINKLE CL, Williams NL, Wu H, Wu J, et al
    Treatment patterns and disease outcomes for pediatric patients with refractory or recurrent Hodgkin lymphoma treated with curative-intent salvage radiotherapy.
    Radiother Oncol. 2019;134:89-95.
    PubMed     Abstract available


    February 2019
  7. AN Y, Jiang W, Andraos TY, Reddy JP, et al
    Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides.
    Radiother Oncol. 2019;131:88-92.
    PubMed     Abstract available


  8. JOURNY N, Mansouri I, Allodji RS, Demoor-Goldschmidt C, et al
    Volume effects of radiotherapy on the risk of second primary cancers: A systematic review of clinical and epidemiological studies.
    Radiother Oncol. 2019;131:150-159.
    PubMed     Abstract available


    December 2018
  9. MODING EJ, Advani R, Rosenberg SA, Hoppe RT, et al
    Prognostic factors and patterns of failure in advanced stage Hodgkin lymphoma treated with combined modality therapy.
    Radiother Oncol. 2018;129:507-512.
    PubMed     Abstract available


    September 2018
  10. STARKE A, Bowden J, Lynn R, Hall K, et al
    Comparison of butterfly volumetric modulated arc therapy to full arc with or without deep inspiration breath hold for the treatment of mediastinal lymphoma.
    Radiother Oncol. 2018 Sep 20. pii: S0167-8140(18)33455.
    PubMed     Abstract available


    May 2018
  11. DENG XW, Wu JX, Wu T, Zhu SY, et al
    Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG).
    Radiother Oncol. 2018 May 5. pii: S0167-8140(18)30217.
    PubMed     Abstract available


    August 2017
  12. RECHNER LA, Maraldo MV, Vogelius IR, Zhu XR, et al
    Life years lost attributable to late effects after radiotherapy for early stage Hodgkin lymphoma: The impact of proton therapy and/or deep inspiration breath hold.
    Radiother Oncol. 2017 Aug 21. pii: S0167-8140(17)32509.
    PubMed     Abstract available


  13. BATES JE, Dhakal S, Mazloom A, Casulo C, et al
    Benefit from the inclusion of radiation therapy in the treatment of patients with stage III classical Hodgkin lymphoma: A propensity matched analysis of the Surveillance, Epidemiology, and End Results database.
    Radiother Oncol. 2017 Aug 1. pii: S0167-8140(17)32475.
    PubMed     Abstract available


    July 2017
  14. FABBRI A, Cencini E, Cerase A, Bocchia M, et al
    New perspectives for patients with primary CNS lymphoma.
    Radiother Oncol. 2017 Jul 4. pii: S0167-8140(17)30426.
    PubMed    


    June 2017
  15. BIRD D, Patel C, Scarsbrook AF, Cosgrove V, et al
    Evaluation of clinical target volume expansion required for involved site neck radiotherapy for lymphoma to account for the absence of a pre-chemotherapy PET-CT in the radiotherapy treatment position.
    Radiother Oncol. 2017 Jun 6. pii: S0167-8140(17)30378.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: